Literature DB >> 9818943

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.

W Kelder1, J C McArthur, T Nance-Sproson, D McClernon, D E Griffin.   

Abstract

Human immunodeficiency virus-associated dementia (HAD) is associated with increased numbers of activated central nervous system (CNS) macrophages. Chemokines, which regulate infiltration of macrophages, were measured in the cerebrospinal fluid (CSF) of human immunodeficiency virus (HIV)-negative and HIV-positive individuals with and without neurological disease. Monocyte chemotactic protein (MCP)-1 and RANTES (but not MCP-3), macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, or interleukin-8 (IL-8) was higher in HAD. MCP-1 correlated with CSF viral load and severity of dementia, and it increased over time in patients who developed dementia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818943     DOI: 10.1002/ana.410440521

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  138 in total

1.  Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro.

Authors:  Ashish K Rehni; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2011-09-20       Impact factor: 4.530

2.  HIV-1 Tat-mediated neurotoxicity in retinal cells.

Authors:  Nivedita Chatterjee; Shannon Callen; Gail M Seigel; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-28       Impact factor: 4.147

3.  Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection.

Authors:  A B Ragin; Y Wu; P Storey; B A Cohen; R R Edelman; L G Epstein
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

4.  HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway.

Authors:  Ankit Shah; Dhirendra P Singh; Shilpa Buch; Anil Kumar
Journal:  Biochem Biophys Res Commun       Date:  2011-09-14       Impact factor: 3.575

Review 5.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

6.  PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation.

Authors:  Toni K Roberts; Eliseo A Eugenin; Susan Morgello; Janice E Clements; M Christine Zink; Joan W Berman
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

7.  Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

Authors:  Kenneth Williams; Susan Westmoreland; Jane Greco; Eva Ratai; Margaret Lentz; Woong-Ki Kim; Robert A Fuller; John P Kim; Patrick Autissier; Prahbat K Sehgal; Raymond F Schinazi; Norbert Bischofberger; Michael Piatak; Jeffrey D Lifson; Eliezer Masliah; R Gilberto González
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 8.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

9.  HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.

Authors:  Eliseo A Eugenin; Gawain Dyer; Tina M Calderon; Joan W Berman
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

10.  Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.

Authors:  Gretja Schnell; Richard W Price; Ronald Swanstrom; Serena Spudich
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.